drugset / Trial / NCT00064363

Talampanel in Treating Patients With Recurrent High-Grade Glioma

NCT00064363

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy such as talampanel use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well talampanel works in treating patients with recurrent, progressive high-grade glioma.

Timeline

Start
2003-06
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Talampanel Small molecule Oral